US Trustee Says Endo Can't Justify $71M In Bonus Pay
The U.S. Trustee's Office is asking a New York bankruptcy judge to reject Endo Pharmaceuticals' request to make bonus payments to its employees, saying the opioid maker has failed to justify...To view the full article, register now.
Already a subscriber? Click here to view full article